N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 25 ((3'r)-1'-{(1p)-5-amino-1-[2-(trifluoromethoxy)phenyl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one)
PDB DOI: 10.2210/pdb10mw/pdb
Classification: HYDROLASE/INHIBITOR Organism(s): Homo Sapiens
Deposited: 2026-01-28 Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , Hicks, J. , Hruza, A. , Je, J. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Poiou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 25 ((3'r)-1'-{(1p)-5-amino-1-[2-(trifluoromethoxy)phenyl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one)
Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , Hicks, J. , Hruza, A. , Je, J. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Poiou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Primary Citation of Related Structures: 10MW
| Proteins | ||||
|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Sequence |
| Plasma kallikrein | A | 275 | Homo Sapiens | KREAEANTGDNSVSTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPAHHHHHH |
Method: X-RAY DIFFRACTION
Deposited Date: 2026-01-28 Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , Hicks, J. , Hruza, A. , Je, J. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Poiou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.